PHARMACOKINETICS AND SAFETY OF A LONG-ACTING SUBCUTANEOUS FORMULATION OF 2-METHOXYESTRADIOL (2ME) IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Tofovic, S. [1 ]
Jackson, E. [2 ,3 ]
Piche, C. [4 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Med, Ctr Clin Pharmacol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Med & Pharmacol, Ctr Clin Pharmacol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Biol Chem, Ctr Clin Pharmacol, Pittsburgh, PA USA
[4] PR Pharmaceut, Ft Collins, CO USA
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV
    Neyens, M.
    Crauwels, H. M.
    Perez-Ruixo, J. J.
    Rossenu, S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (12) : 3255 - 3262
  • [32] Safety and pharmacokinetics of a long-acting glycopegylated rFVIIa derivative: a first human dose trial in healthy subjects
    Moss, J.
    Rosholm, A.
    Lauren, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 222 - 222
  • [33] Safety and pharmacokinetics of single doses of aclidinium bromide, a novel long-acting, inhaled antimuscarinic, in healthy subjects
    Jansat, J. M.
    Lamarca, R.
    Garcia Gil, E.
    Ferrer, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (07) : 460 - 468
  • [34] A study evaluating the safety, tolerability, and pharmacokinetics of a high-concentration (CAB 400 mg/ml) cabotegravir long-acting injectable formulation following subcutaneous and intramuscular administration in healthy adult participants
    Benn, P.
    Han, K.
    Sievers, J.
    Shaik, J. Sadik
    Warwick-Sanders, M.
    Win, B.
    Dorey, D.
    Baker, M.
    Leemereise, C.
    Offenbecker, K.
    Garis, C.
    Brimhall, D. B.
    Boyle, C.
    Schwabe, C.
    Taylor, D.
    Hassman, M. A.
    Wolstenholme, A.
    Knowles, S.
    Spreen, W.
    Lataillade, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 125 - 126
  • [35] The tolerability, safety, pharmacokinetics, and pharmacodynamics of TX000045, a long-acting Fc-relaxin fusion protein after single doses in healthy volunteers
    Ruddy, Marcella
    West, Mary
    Milton, Mark
    Muslin, Anthony
    CIRCULATION, 2024, 150
  • [36] Long-acting β2-agonists in asthma:: safety concerns
    Wooltorton, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (09) : 1030 - 1031
  • [37] Safety updates for long-acting β2-agonists in the US
    Reactions Weekly, 2005, 1069 (1) : 3 - 3
  • [38] Safety Profile of long-acting β2-Agonists in Asthma
    Rukavina, Marion
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (18) : 1290 - 1290
  • [39] Safety Trials of Long-Acting β2-Agonists REPLY
    Busse, William W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1482 - 1482
  • [40] Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects
    Mikkel Askjær Agersnap
    Kim Sonne
    Kim Mark Knudsen
    Carsten Boye Knudsen
    Mark Berner-Hansen
    Clinical Drug Investigation, 2022, 42 : 1093 - 1100
12345